Biogen BIIB
NASDAQ BIIB
$222.82 -3.06 (-1.35%)
At close: Oct 1, 2026 · 4:00 PM EDT

Biogen (BIIB) Work In Process (2010 - 2018)

Updated

Biogen's Work In Process came in at $606.7 million for Q4 2018, up 0.2% from $605.7 million a year earlier.

Analysis

Biogen (BIIB) Work In Process (2010 - 2018) Analysis & Trends

Going back to Q4 2010, Biogen's Work In Process data covers 12 quarters.

  • Work In Process carries a five-year compound annual growth rate of 6.9% (FY2013 to FY2018).
  • Going back by year, Work In Process was $605.7 million in FY2017 (-13.3%), $698.7 million in FY2016 (+21.0%), $577.6 million in FY2015 (+12.9%) and $511.5 million in FY2014 (+17.5%).
  • The Q4 2018 figure represents the highest quarterly Work In Process since Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Biogen 33.37 Bn 20.03 Bn 1.96 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 606.70 Mn
Dec 31, 2017 605.70 Mn
Dec 31, 2016 698.70 Mn
Dec 31, 2015 577.60 Mn
Dec 31, 2014 511.50 Mn
Dec 31, 2013 435.40 Mn
Mar 31, 2013 276.10 Mn
Dec 31, 2012 244.90 Mn
Jun 30, 2012 166.80 Mn
Mar 31, 2012 163.50 Mn
Dec 31, 2011 169.40 Mn
Dec 31, 2010 142.20 Mn
API Access

Biogen Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=BIIB&period=max&api_key=YOUR_API_KEY